MedPath

MARDAN MEDICAL COMPLEX

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Early Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (100.0%)

Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis

Early Phase 1
Completed
Conditions
Acute Bronchiolitis
Interventions
Drug: steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline
Drug: 3% normal saline
First Posted Date
2023-11-18
Last Posted Date
2023-11-21
Lead Sponsor
Mardan Medical Complex
Target Recruit Count
60
Registration Number
NCT06139029
Locations
🇵🇰

Faizan Sadiq, Mardan, Kpk, Pakistan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.